Casi pharmaceuticals partner, bioinvent, to host key opinion leader call on bi-1206 for relapsed or refractory non-hodgkin's lymphoma

Rockville, md. and beijing, jan. 21, 2021 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a u.s. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces that its partner bioinvent international ab...
CASI Ratings Summary
CASI Quant Ranking